WESAIL WESAIL
  • Home
  • About us
  • Products
    Fluorescence Immunoassay (FIA) Chemiluminescence Immunoassay (CLIA) Rapid Test (Colloidal gold) Quality Control
  • Solution
    Chest Pain Center Stroke Center Trauma Center Critical Maternal Care Center Critical Children and Neonatal Care Center Center for Reproductive Medicine Hierarchical diagnosis and treatment Hospital-wide solution
  • News
  • User Services
  • Join us
  • 中文
  • +86 -755-23577939
  • 
  • 中文 English
WESAIL
  • Home
  • About us
  • Products

    Fluorescence Immunoassay (FIA)

    Chemiluminescence Immunoassay (CLIA)

    Rapid Test (Colloidal gold)

    Quality Control

  • Solution

    Chest Pain Center

    Stroke Center

    Trauma Center

    Critical Maternal Care Center

    Critical Children and Neonatal Care Center

    Center for Reproductive Medicine

    Hierarchical diagnosis and treatment

    Hospital-wide solution

  • News
  • User Services
  • Join us
  • 中文
  • CN

News Center
News Center
  • Home page
All categories

Notification publicity
Market Activity
Company Dynamics

Feb 08,2024

Medlab Dubai 2024


Medlab Dubai 2024

Oct 27,2020

WESAIL Appears at 2020 China (Dongguan) International Medical Epidemic Prevention and Big Health Industry Development Forum and Exhibition


From October 19 to 20, 2020, Guangdong Weishi Biotechnology Co., Ltd. participated in the "2020 Dongguan International Medical Epidemic Prevention and Great Health Exhibition"

WESAIL Appears at 2020 China (Dongguan) International Medical Epidemic Prevention and Big Health Industry Development Forum and Exhibition

Mar 30,2021

WESAIL debuts at CACLP to make POCT easier, faster and more accurate


Guangdong Weishi Biotechnology Co., Ltd. (hereinafter referred to as "WESAIL") and its star products independently developed and produced by the company were invited to participate in the flagship expo event of in vitro diagnosis industry -- CACLP.

WESAIL debuts at CACLP to make POCT easier, faster and more accurate

Nov 17,2021

WESAIL debuts at MEDICA 2021 to share innovations with the world!


WESAIL debuts at MEDICA 2021 to share innovations with the world!

Nov 15,2022

More than 50% of Chinese adults have diabetes or are in the pre-disease stage. See here for diagnostic criteria.


More than 50% of Chinese adults have diabetes or are in the pre-disease stage. See here for diagnostic criteria.

Nov 21,2022

"Only" innovation, win the future! Guangdong Weishi biological new products unveiled in 2022 Germany MEDICA medical exhibition


"Only" innovation, win the future! Guangdong Weishi biological new products unveiled in 2022 Germany MEDICA medical exhibition
< 1 > proceed page
Picture Name
  • Home

  • About us

  • Products

    • Fluorescence Immunoassay (FIA)

      • Reagent

      • Analyzers

    • Chemiluminescence Immunoassay (CLIA)

      • Reagent

      • Instrument

    • Rapid Test (Colloidal gold)

    • Quality Control

      • Cardiac markers

      • Thrombus

      • Inflammation

      • Renal function

      • Thyroid function

      • Diabetes

      • Bone metabolism

      • Gastric function

      • Pregnancy

      • Reproductive function

      • Anemia

      • Other

  • Solution

    • Chest Pain Center

    • Stroke Center

    • Trauma Center

    • Critical Maternal Care Center

    • Critical Children and Neonatal Care Center

    • Center for Reproductive Medicine

    • Hierarchical diagnosis and treatment

    • Hospital-wide solution

  • News

  • User Services

  • Join us

  • 中文

Telephone:4009001339
Mail:customer-cn@wesailbio.com
Address: Room 403, Building 1, No.1 Taoyuan Road, Songshan Lake Park, Dongguan City, Guangdong Province

facebook
Instagram
youtube

©COPYRIGHT 2023 Guangdong Weishi Biotechnology Co., Ltd. ALL RIGHTS RESERVED Website Construction:China Enterprise Power  Shenzhen   SEO

Business License

©COPYRIGHT 2023 Guangdong Weishi Biotechnology Co., Ltd.

Website construction:China Enterprise Power Shenzhen  SEO

Skype

4

Skype

12321321

E-mail

8

E-mail

customer-cn@wesailbio.com

Tel

9

Tel

4009001339